Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
jinhua zhou
CONTACT
Lead
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Main study purpose: To assess the safety and tolerability of IMM0306 in combination with lenalidomide to determine the maximum tolerated dose (MTD) (if available) and the recommended Phase 2 dose (RP2D). Secondary study purpose 1. To assess the antitumor efficacy of IMM0306 in combination with lenalidomide. 2. To assess the immunogenicity of IMM0306 in combination with lenalidomide. 3. To evaluate the pharmacokinetic (PK) profile of IMM0306 in combination with lenalidomide. Exploratory study purpose: 1. Explore the correlation between exposure to IMM0306 and efficacy and safety (data permitting). 2. Explore the correlation of biomarkers with safety.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted